Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Braskem S.A.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Braskem S.A. (“Braskem” or “the Company”) (NYSE: BAK). Investors who purchased Braskem securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether Braskem has violated federal securities laws.
Investigation Details
On September 26, 2025, Braskem announced that it had “retained financial and legal advisors to support the Company in preparing a diagnosis of economic-financial alternatives to optimize its capital structure.” Following this news, Braskem’s ADR price dropped more than 14.7% on the same day.
What’s Next?
If you are aware of any facts relating to this investigation or purchased Braskem securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660
BAK — Stock Performance
About Bronstein, Gewirtz & Grossman, LLC
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”